Avalo Therapeutics Overview
Avalo Therapeutics Discounted Cash Flow
DCF Analysis for AVTX.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.99
Current Fair Value
$0.99
↓ 93.2% Downside
Overvalued by 93.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison